Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG)

Hishiki Tomoro; Matsumoto Kimikazu; Ohira Miki; Kamijo Takehiko; Shichino Hiroyuki; Kuroda Tatsuo; Yoneda Akihiro; Soejima Toshinori; Nakazawa Atsuko; Takimoto Tetsuya; Yokota Isao; Teramukai Satoshi; Takahashi Hideto; Fukushima Takashi; Kaneko Takashi; Hara Junichi; Kaneko Michio; Ikeda Hitoshi; Tajiri Tatsuro; Nakagawara Akira

首页> 外文期刊>International journal of clinical oncology >Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG)

【24h】

Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG)

机译：高风险神经母细胞瘤治疗协议的II期试验结果JN-H-07：日本儿童癌细胞神经母细胞瘤委员会的报告（JNBSG）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

The Japanese Children's Cancer Group (JCCG) Neuroblastoma Committee (JNBSG) conducted a phase II clinical trial for high-risk neuroblastoma treatment. We report the result of the protocol treatment and associated genomic aberration studies.

机译：日本儿童癌症组（JCCG）神经母细胞瘤委员会（JNBSG）进行了一项临床试验，用于高危神经母细胞瘤治疗。我们报告了协议治疗和相关基因组畸变研究的结果。

著录项

来源
《International journal of clinical oncology》 |2018年第5期|共9页
作者
Hishiki Tomoro; Matsumoto Kimikazu; Ohira Miki; Kamijo Takehiko; Shichino Hiroyuki; Kuroda Tatsuo; Yoneda Akihiro; Soejima Toshinori; Nakazawa Atsuko; Takimoto Tetsuya; Yokota Isao; Teramukai Satoshi; Takahashi Hideto; Fukushima Takashi; Kaneko Takashi; Hara Junichi; Kaneko Michio; Ikeda Hitoshi; Tajiri Tatsuro; Nakagawara Akira;
展开▼
作者单位

Natl Ctr Child Hlth &

Dev Childrens Canc Ctr Setagaya Ku 2-10-1 Okura Tokyo 1578535 Japan;

Natl Ctr Child Hlth &

Dev Childrens Canc Ctr Setagaya Ku 2-10-1 Okura Tokyo 1578535 Japan;

Saitama Canc Ctr Res Inst Clin Oncol Ina Saitama Japan;

Saitama Canc Ctr Res Inst Clin Oncol Ina Saitama Japan;

Natl Ctr Global Hlth &

Med Pediat Tokyo Japan;

Keio Univ Sch Med Pediat Surg Tokyo Japan;

Osaka City Gen Hosp Pediat Surg Osaka Japan;

Kobe Proton Ctr Kobe Hyogo Japan;

Natl Ctr Child Hlth &

Dev Pathol Tokyo Japan;

Natl Ctr Child Hlth &

Dev Clin Epidemiol Res Ctr Pediat Canc Tokyo Japan;

Kyoto Prefectural Univ Med Biostat Kyoto Japan;

Kyoto Prefectural Univ Med Biostat Kyoto Japan;

Natl Inst Publ Hlth Wako Saitama Japan;

Univ Tsukuba Fac Med Pediat Tsukuba Ibaraki Japan;

Tokyo Metropolitan Childrens Med Ctr Hematol &

Oncol Tokyo Japan;

Osaka City Gen Hosp Pediat Hematol &

Oncol Osaka Japan;

Ibaraki Prefectural Assoc Hlth Evaluat &

Promot Mito Ibaraki Japan;

Dokkyo Med Univ Koshigaya Hosp Pediat Surg Koshigaya Japan;

Kyoto Prefectural Univ Med Pediat Surg Kyoto Japan;

Saga Med Ctr KOSEIKAN Hosp Saga Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Neuroblastoma; High-risk; Clinical trial; Surgery; Genomic signature; Multidisciplinary treatment;

机译：神经母细胞瘤;高风险;临床试验;手术;基因组签名;多学科治疗;

相似文献

外文文献
中文文献
专利

1. Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG) [J] . Hishiki Tomoro, Matsumoto Kimikazu, Ohira Miki, International journal of clinical oncology . 2018,第5期

机译：高风险神经母细胞瘤治疗协议的II期试验结果JN-H-07：日本儿童癌细胞神经母细胞瘤委员会的报告（JNBSG）
2. Topotecan, cyclophosphamide, and etoposide (TCE) in the treatment of high-risk neuroblastoma. Results of a phase-II trial [J] . Thorsten Simon, Alfred L?ngler, Urs Harnischmacher, Journal of Cancer Research and Clinical Oncology . 2007,第9期

机译：托泊替康，环磷酰胺和依托泊苷（TCE）用于治疗高危神经母细胞瘤。 II期试验的结果
3. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the Worl [J] . Koops HS, Vaglini M, Suciu S, Journal of Clinical Oncology . 1998,第9期

机译：局部性高危肢体黑色素瘤的预防性孤立肢体灌注：一项多中心随机III期试验的结果。欧洲癌症恶性黑色素瘤研究与治疗组织合作小组协议18832，世界
4. Treatment on Neuroblastoma Cancer Cells Using Atmospheric Cold Plasma [C] . Magesh T. Rajan, Krishna Patel, Sreeja Vemulapalli, IEEE International Conference on Plasma Science . 2017

机译：大气冷血浆对神经母细胞瘤癌细胞的治疗
5. Recruitment, retention and compliance in randomized, phase III clinical trials involving obese patients diagnosed with type 2 Diabetes Mellitus with respect to weight loss practicum report. [D] . Mithani, Moez S. 2012

机译：涉及诊断为2型糖尿病的肥胖患者的有关减肥实践的随机III期临床试验中的招募，保留和依从性报告。
6. Trastuzumab pertuzumab and eribulin mesylate versus trastuzumab pertuzumab and a taxane as a first-line or second-line treatment for HER2-positive locally advanced or metastatic breast cancer: study protocol for a randomized controlled non-inferiority phase III trial in Japan (JBCRG-M06/EMERALD) [O] . Toshinari Yamashita, Norikazu Masuda, Shigehira Saji, 2020

机译：曲妥珠单抗帕妥珠单抗和甲磺酸艾瑞布林与曲妥珠单抗帕妥珠单抗和紫杉烷作为一线或二线治疗HER2阳性局部晚期或转移性乳腺癌的一线或二线治疗：III期随机对照非劣效性的研究方案在日本试用（JBCRG-M06 / EMERALD）
7. Correction to: Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG) [O] . Tomoro Hishiki, Kimikazu Matsumoto, Miki Ohira, 2020

机译：矫正：高风险神经母细胞瘤治疗协议的II期试验JN-H-07：日本儿童癌细胞癌神经母细胞瘤委员会的报告（JNBSG）

Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG)

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅